Cancer antineovascular therapy

Cell Mol Biol Lett. 2002;7(2):247-8.

Authors

Naoto Oku¹, Tomohiro Asai, Kohta Kurohane, Koh Watanabe, Koichi Kuromi, Yukihiro Namba, Koichi Ogino, Takao Taki

Affiliation

¹ Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Yada, Shizuoka 422-8526 Japan.

PMID: 12097936

No abstract available

Publication types

Lecture

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / therapeutic use*
Animals
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use*
Arabinonucleotides / administration & dosage*
Arabinonucleotides / therapeutic use
Drug Carriers
Endothelium, Vascular / cytology
Endothelium, Vascular / drug effects
Humans
Liposomes
Mice
Neovascularization, Pathologic*
Oligopeptides
Photochemotherapy / methods*
Porphyrins / administration & dosage*
Porphyrins / therapeutic use
Radiation-Sensitizing Agents / administration & dosage*
Radiation-Sensitizing Agents / therapeutic use
Sarcoma / drug therapy

Substances

Angiogenesis Inhibitors
Antineoplastic Agents
Arabinonucleotides
Drug Carriers
Liposomes
Oligopeptides
Porphyrins
Radiation-Sensitizing Agents
dpp-cndac
benzoporphyrin D